Polpharma Starogard Gdanski puts finishing touches on zl.256 mn. plant

Pharmaceutical company Polpharma Starogard Gdanski is putting the final touches on construction of a new medicine production plant to be known as Formy Suche II. So far the company has invested zl.237 million and the final total investment will be zl.19 million higher. The plant is currently being equipped and when that is completed the production capacity of Polpharma is envisaged to increase from 3.6 billion pills and capsules annually to over 5 billion. " The new plant will guarantee us the ability to introduce five new medicines annually to the Polish pharmaceutical market," says Polpharma president Pavel Mirovski. Polpharma is the largest pharmaceutical producer in Poland and one of the largest in Middle and Eastern Europe. It was privatized last year, with a consortium of Spectra Management and Prokom Investment holding a 52.5% stake. (Rzeczpospolita, p.B3) A.Z.